3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioma
2
Disease
2
Carcinoma in Situ
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lymphoma, Non-Hodgkin
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hypoxia
1
Interventions
Rituximab
5
Specimen Handling
3
Cyclophosphamide
3
Biopsy
3
ibrutinib
2
fludarabine
2
binimetinib
2
Vemurafenib
2
Cladribine
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
obinutuzumab
1
immunotoxin HA22
1
fludarabine phosphate
1
encorafenib
1
brexucabtagene autoleucel
1
acalabrutinib
1
Whole-Body Irradiation
1
Transplantation
1
Tacrolimus
1
Spinal Puncture
1
Radiotherapy
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
Magnetic Resonance Imaging
×
90 days
×
Clear all
No trials found.